HYDERABAD, July 7 (Reuters) - Demand for weight-loss drugs is rising at a fast clip in India where rivals Eli Lilly (LLY.N), ...

Weight loss injections promise quick results, but skipping blood screening can trigger serious risks like pancreatitis or ...

CVS Caremark has removed coverage of Zepbound, a GLP-1 weight-loss drug, citing pricing concerns and shifting payer dynamics ...

By Elizabeth Shockman, MPR News acing a massive increase in employee health insurance rates, leaders at Anoka-Hennepin Area Schools last May asked a question out loud: Should the district stop paying ...